50090-2062 : Tenivac Intramuscular Injection, Suspension


NDC50090-2062
Labeler: A-s Medication Solutions
Product Type: Vaccine
Drug Name: Tenivac
Dosage Form: Intramuscular Injection, Suspension
Application #: BLA103171
Rev. Date: 


NDC Package Codes:

  • 50090-2062-0: 10 SYRINGE IN 1 PACKAGE (50090‑2062‑0) / .5 ML IN 1 SYRINGE (50090‑2062‑1)

Active Ingredients:

  • Clostridium Tetani Toxoid Antigen (Formaldehyde Inactivated)
  • Corynebacterium Diphtheriae Toxoid Antigen (Formaldehyde Inactivated)

Dosage Strength:

  • 5 [Lf]/.5mL
  • 2 [Lf]/.5mL

Pharmaceutical Classes:

  • Actively Acquired Immunity [PE]
  • Actively Acquired Immunity [PE]
  • Diphtheria Toxoid [CS]
  • Inactivated Clostridium Tetani Vaccine [EPC]
  • Inactivated Corynebacterium Diphtheriae Vaccine [EPC]
  • Tetanus Toxoid [CS]
  • Vaccines
  • Inactivated [CS]

Related Products:

Based on records with the same trade name.
  • 49281-215 Tenivac Intramuscular Injection, Suspension by Sanofi Pasteur Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 50090-2062 QR Code

< Prev: 50090-2061Next: 50090-2063 >

Related Discussions:

Clostridium Butyricum as Probiotic
bacillus mesentericus TO-A JPC 1 million, clostridium butyricum TO-A 2 million, lactobacillus 50 million, Streptococcus ... 2 replies
Typhivex VI Antigen
We are the manufacture of Typhoid vaccine VI Antigen Based and typhoid diagnostic reagent name, Typhidot, monoclonal ant... 1 reply
formaldehyde
formaldehyde 4% in normal saline prescibed for verrucas for 10 yr old son no usage directions help pls...
Alinia for clostridium
Can Alinia treat clostridium?...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.